On the other hand, if you like your ObamaCare, you can keep your ObamaCare. Period.

  • by: |
  • 11/14/2013

Sebelius & Co. have released enrollment numbers. Some key findings:

* 106,185 people have selected an Exchange plan (although not all have paid the premium).  This includes 26,794 people in the federal exchange states. 

* 396,261 people whose applications were processed by the Exchanges have been deemed eligible for Medicaid.  A little more than half of those people live in states with state-based exchanges.

* Surprisingly, of those deemed eligible for Marketplace plan enrollment, only 30% qualified for a premium tax credit.  CBO had expected about 80% of Exchange enrollees would qualify for a premium tax credit.

* About a million people have been deemed eligible for Exchange coverage but have not yet picked a plan.  It’s not clear if these people will pick a plan later on or decided not to enroll – especially if their “cancelled” plans are reinstated.

* The HHS release includes a long appendix comparing Exchange enrollment to Part D, Massachusetts Commonwealth Care, CHIP and FEHBP.  While Part D had about 10% enrollment in the first month, Massachusetts had just 3% enrollment in the first month (and the Bay State kept enrollment open for the entire first year so there was less pressure to enroll early).

* If exchange enrollment mirrors the same enrollment pattern as Part D, about 700,000 people would have to enroll by the end of November in order to meet the target of 7,000,000 people enrolled in Exchanges in 2014.

And speaking of exchanges, Gallup has found that just 18% of uninsured adults had attempted to visit an Exchange website.

Technical notes:

* This report only captures enrollment through Nov 2.

* Data includes applications submitted through methods other than the website (i.e. paper applications).

* There are state-by-state tables included in the release (see page 9).

The complete HHS release can be found here.


Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
Better Health
Biotech Blog
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
Envisioning 2.0
FDA Law Blog
Fierce Pharma
Fresh Air Fund
Furious Seasons
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
In the Pipeline
In Vivo
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
More than Medicine
National Review
Neuroethics & Law
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmacology Corner
Pharmaceutical Business Review
Piper Report
Prescription for a Cure
Public Plan Facts
Real Clear Politics
Shark Report
Shearlings Got Plowed
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog